Phase I study of humanised antibody A33 (Hua33) in patients with colorectal carcinoma - Preliminary whole body clearance and tumour dosimetry: Short title: Dosimetric analysis of [I-131]huA33

A. Hanna; P. U; A. Wallace; P. Schleyer; F. T. Lee; R. Jones; W. Hopkins; D. MacGregor; J. Cebon; A. Rigopoulos; D. Thomas; W. J. McKay; S. Welt; E. Richards; K. S. Kolbert; G. Sgouros; L. Old; A. W. Burgess; A. M. Scott

Phase I study of humanised antibody A33 (Hua33) in patients with colorectal carcinoma - Preliminary whole body clearance and tumour dosimetry: Short title: Dosimetric analysis of [I-131]huA33

A. Hanna, P. U, A. Wallace, P. Schleyer, F. T. Lee, R. Jones, W. Hopkins, D. MacGregor, J. Cebon, A. Rigopoulos, D. Thomas, W. J. McKay, S. Welt, E. Richards, K. S. Kolbert, G. Sgouros, L. Old, A. W. Burgess, A. M. Scott

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	52-55
Number of pages	4
Journal	ANZ Nuclear Medicine
Volume	30
Issue number	2
State	Published - 1999
Externally published	Yes

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Cite this

Hanna, A., U, P., Wallace, A., Schleyer, P., Lee, F. T., Jones, R., Hopkins, W., MacGregor, D., Cebon, J., Rigopoulos, A., Thomas, D., McKay, W. J., Welt, S., Richards, E., Kolbert, K. S., Sgouros, G., Old, L., Burgess, A. W., & Scott, A. M. (1999). Phase I study of humanised antibody A33 (Hua33) in patients with colorectal carcinoma - Preliminary whole body clearance and tumour dosimetry: Short title: Dosimetric analysis of [I-131]huA33. ANZ Nuclear Medicine, 30(2), 52-55.

Hanna, A, U, P, Wallace, A, Schleyer, P, Lee, FT, Jones, R, Hopkins, W, MacGregor, D, Cebon, J, Rigopoulos, A, Thomas, D, McKay, WJ, Welt, S, Richards, E, Kolbert, KS, Sgouros, G, Old, L, Burgess, AW & Scott, AM 1999, 'Phase I study of humanised antibody A33 (Hua33) in patients with colorectal carcinoma - Preliminary whole body clearance and tumour dosimetry: Short title: Dosimetric analysis of [I-131]huA33', ANZ Nuclear Medicine, vol. 30, no. 2, pp. 52-55.

@article{d85a93fbb13a47f8a1602d62c99143c2,

title = "Phase I study of humanised antibody A33 (Hua33) in patients with colorectal carcinoma - Preliminary whole body clearance and tumour dosimetry: Short title: Dosimetric analysis of [I-131]huA33",

author = "A. Hanna and P. U and A. Wallace and P. Schleyer and Lee, {F. T.} and R. Jones and W. Hopkins and D. MacGregor and J. Cebon and A. Rigopoulos and D. Thomas and McKay, {W. J.} and S. Welt and E. Richards and Kolbert, {K. S.} and G. Sgouros and L. Old and Burgess, {A. W.} and Scott, {A. M.}",

year = "1999",

language = "English (US)",

volume = "30",

pages = "52--55",

journal = "ANZ Nuclear Medicine",

issn = "1324-1435",

publisher = "Australian and New Zealand Society of Nuclear Medicine Inc.",

number = "2",

}

TY - JOUR

T1 - Phase I study of humanised antibody A33 (Hua33) in patients with colorectal carcinoma - Preliminary whole body clearance and tumour dosimetry

T2 - Short title: Dosimetric analysis of [I-131]huA33

AU - Hanna, A.

AU - U, P.

AU - Wallace, A.

AU - Schleyer, P.

AU - Lee, F. T.

AU - Jones, R.

AU - Hopkins, W.

AU - MacGregor, D.

AU - Cebon, J.

AU - Rigopoulos, A.

AU - Thomas, D.

AU - McKay, W. J.

AU - Welt, S.

AU - Richards, E.

AU - Kolbert, K. S.

AU - Sgouros, G.

AU - Old, L.

AU - Burgess, A. W.

AU - Scott, A. M.

PY - 1999

Y1 - 1999

UR - http://www.scopus.com/inward/record.url?scp=0032986482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032986482&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032986482

SN - 1324-1435

VL - 30

SP - 52

EP - 55

JO - ANZ Nuclear Medicine

JF - ANZ Nuclear Medicine

IS - 2

ER -

Phase I study of humanised antibody A33 (Hua33) in patients with colorectal carcinoma - Preliminary whole body clearance and tumour dosimetry: Short title: Dosimetric analysis of [I-131]huA33

ASJC Scopus subject areas

Other files and links

Cite this